Parkinson's Disease Treatment With Coenzyme Q10

Completed · Phase 2

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to compare the effects of varying dosage of coenzyme Q10 (CoQ10) versus a placebo in the treatment of Parkinson's disease (PD) in patients with early, untreated PD.

Key facts

Study ID

NCT00004731

Run by

National Institute of Neurological Disorders and Stroke (NINDS)

Starts

1998-09-01

Expected to finish

2003-10-01

Last updated by the study team

2005-06-24

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subjects must have the three cardinal features of PD: slowness of movement, resting tremor and rigidity. The signs of PD must be greater on one side.

You may not qualify if…

• Disorders that mimic PD.
• Other serious medical problems.

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.